Indications and uses
For the relief of nausea associated with upset/sour stomach, including that due to overindulgence in food and drink.
For the relief of nausea associated with upset/sour stomach, including that due to overindulgence in food and drink.
Adults: 2 - 4 tablets. Children: Consult a doctor for appropriate dosage. Chew tablets completely. Dosage may be repeated after 15 minutes, not to exceed 24 tablets in a 24-hour period unless advised by a doctor. Read all package directions and warning before use and use only as directed. Nauzene Chewables are intended for use by normally healthy persons only. Persons under 18 years of age should use only as dire...
Sodium citrate dihydrate 230 mg
Upset stomach reliever/antacid
For the relief of nausea associated with upset/sour stomach, including that due to overindulgence in food and drink.
Do not use if you have Hereditary Fructose Intolerance (HFI). This product contains fructose.
Ask a doctor or pharmacist before use if you are taking any other medications. This product may interact with certain prescription drugs.
When using this product, do not take more than 24 tablets in a 24-hour period.
Stop use and ask a doctor if nausea lasts more than two weeks or recurs frequently.
If pregnant or breastfeeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Aspartame, bitter masking salt, dextrose, FDC Red No. 40 Lake, flavors, food starch-modified, fructose, hypromellose, magnesium stearate, maltodextrin, povidone, silicon dioxide, stearic acid, sucrose.
Questions? 1-800-792-2582
| Class | Version | Type | Effective |
|---|---|---|---|
| ANHYDROUS CITRIC ACID Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52389-242-10 | Nauzene | 1 in 1 CARTON | TABLET, CHEWABLE | 1 | 15 | |
| 52389-242-10 | Nauzene | 10 in 1 BLISTER PACK | TABLET, CHEWABLE | 10 | 15 | |
| 52389-242-40 | Nauzene | 4 in 1 CARTON | TABLET, CHEWABLE | 4 | 15 | |
| 52389-242-40 | Nauzene | 10 in 1 BLISTER PACK | TABLET, CHEWABLE | 10 | 15 | |
| 52389-242-42 | Nauzene | 14 in 1 BLISTER PACK | TABLET, CHEWABLE | 14 | 15 | |
| 52389-242-42 | Nauzene | 3 in 1 CARTON | TABLET, CHEWABLE | 3 | 15 | |
| 52389-242-50 | Nauzene | 10 in 1 BLISTER PACK | TABLET, CHEWABLE | 10 | 15 | |
| 52389-242-50 | Nauzene | 5 in 1 CARTON | TABLET, CHEWABLE | 5 | 15 | |
| 52389-242-56 | Nauzene | 14 in 1 BLISTER PACK | TABLET, CHEWABLE | 14 | 15 | |
| 52389-242-56 | Nauzene | 4 in 1 CARTON | TABLET, CHEWABLE | 4 | 15 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TRISODIUM CITRATE DIHYDRATE | ACTIVE INGREDIENT | B22547B95K | 3 | |
| ANHYDROUS CITRIC ACID | ACTIVE MOIETY | XF417D3PSL | 3 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | 3 | |
| DEXTROSE | INACTIVE INGREDIENT | IY9XDZ35W2 | 3 | |
| FD&C Red No. 40 | INACTIVE INGREDIENT | WZB9127XOA | 3 | |
| FRUCTOSE | INACTIVE INGREDIENT | 6YSS42VSEV | 3 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 3 | |
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 3 | |
| Maltodextrin | INACTIVE INGREDIENT | 7CVR7L4A2D | 3 | |
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | INACTIVE INGREDIENT | 461P5CJN6T | 3 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | 3 | |
| Silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 3 | |
| Stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 3 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 52389-242 | 52389-242-40, 52389-242-42, 52389-242-50, 52389-242-10, 52389-242-56 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ASPARTAME | Z0H242BBR1 | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| DEXTROSE | IY9XDZ35W2 | IACT |
| FRUCTOSE | 6YSS42VSEV | IACT |
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | 461P5CJN6T | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| POVIDONE K30 | U725QWY32X | IACT |
| SUCROSE | C151H8M554 | IACT |
| TRISODIUM CITRATE DIHYDRATE | B22547B95K | ACTIM |
| CHERRY | BUC5I9595W | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, CHEWABLE / ORAL | 1286 mg | ||
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | 461P5CJN6T | CAPSULE / ORAL | 107 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | TABLET / ORAL | 64.92 mg | ||
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | 461P5CJN6T | SUSPENSION / ORAL | 920 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 72 mg | ||
| Silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | 461P5CJN6T | SUSPENSION / ORAL | 920 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | POWDER, FOR SUSPENSION / ORAL | 6000 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SUSPENSION / ORAL | 20 mg/1ml | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | POWDER, FOR SOLUTION / ORAL | 2625 mg/5ml | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SOLUTION / ORAL | 13872 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, CHEWABLE / ORAL | 1286 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SYRUP / ORAL | 1732.5 mg/5ml | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | TABLET / ORAL | 64.92 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SOLUTION / ORAL | 13872 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | POWDER, FOR SOLUTION / ORAL | 2625 mg/5ml | ||
| Stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| Stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SOLUTION / ORAL | 13872 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | POWDER, FOR SUSPENSION / ORAL | 6000 mg | ||
| Aspartame | ASPARTAME | Z0H242BBR1 | TABLET, CHEWABLE / ORAL | 195 mg | ||
| Silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SUSPENSION / ORAL | 20 mg/1ml | ||
| Aspartame | ASPARTAME | Z0H242BBR1 | TABLET, CHEWABLE / ORAL | 195 mg | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, CHEWABLE / ORAL | 40 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SUSPENSION / ORAL | 20 mg/1ml | ||
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | 461P5CJN6T | SUSPENSION / ORAL | 920 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | POWDER, FOR SUSPENSION / ORAL | 6000 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, CHEWABLE / ORAL | 1286 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, CHEWABLE / ORAL | 11.8 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | POWDER, FOR SOLUTION / ORAL | 2625 mg/5ml | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SUSPENSION / ORAL | 20 mg/1ml | ||
| Stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| Silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | 461P5CJN6T | CAPSULE / ORAL | 107 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | POWDER, FOR SUSPENSION / ORAL | 6000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 72 mg | ||
| Silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, CHEWABLE / ORAL | 11.8 mg | ||
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | 461P5CJN6T | CAPSULE / ORAL | 107 mg | ||
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | 461P5CJN6T | CAPSULE / ORAL | 107 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, CHEWABLE / ORAL | 48 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, CHEWABLE / ORAL | 48 mg | ||
| Aspartame | ASPARTAME | Z0H242BBR1 | TABLET, CHEWABLE / ORAL | 195 mg | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, CHEWABLE / ORAL | 40 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SYRUP / ORAL | 1732.5 mg/5ml | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | POWDER, FOR SUSPENSION / ORAL | 6000 mg | ||
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | 461P5CJN6T | SUSPENSION / ORAL | 920 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| Aspartame | ASPARTAME | Z0H242BBR1 | TABLET, CHEWABLE / ORAL | 195 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SUSPENSION / ORAL | 20 mg/1ml | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SYRUP / ORAL | 1732.5 mg/5ml | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, CHEWABLE / ORAL | 48 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nauzene | SODIUM CITRATE | Kobayashi Healthcare International, Inc. | a60660b2-c5db-45a0-885f-de93e655380d | 2025-04-29 | Warnings | 52389-242-50 52389-242-40 52389-242-42 52389-242-10 52389-242-56 52389-242 52389024250 52389024242 52389024256 52389024240 52389024210 2d7c94e6-382b-1655-e063-6394a90a712d a60660b2-c5db-45a0-885f-de93e655380d |
Adverse event summaries are temporarily unavailable. Other product information remains available.